Janssen India, a divison of  Johnson & Johnson, encourages high performance culture amongst its 700+ employees.

Walk - In -Interview for the following position will be held on dated 27.05.2011 at 11.00 a.m. in the Office of the Assistant Director-in-charge, National Research Institute for Ayurveda -Siddha Human Resource Development, Aamkho, Gwalior-474009 (MP.). The selection procedure will comprise of a written test followed by interview of candidates who qualify in the written test, on the same day :-

Symbiotec Pharmalab Ltd., a cortico-steroids API manufacturing company based at Indore in Central India is in the business of development, production and marketing of research-based cortico steroids.

Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world.

Stabicon Life Sciences is a Contract Research Organization offering stability study management and analytical development services.

Marion Biotech strongly believes in an integrated approach to healthcare. It is also engaged in extensive Research & Development of unique Herbal products. At Marion Biotech, we set Stringent Standards of Quality, Safety and Efficacy for all the Products that we manufacture.

Kopran is the group company of Parijat Enterprises. Kopran is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.

At Dr. Reddy’s, a global pharmaceutical company, you will contribute to making the breakthroughs of tomorrow a reality today! From making medicines more affordable to discovering innovative treatment options to satisfy unmet medical needs, we are dedicated to helping people lead longer and healthier lives. We are seeking dynamic and energetic individuals ready to inspire, ready to make a difference for their community and every community.

Eisai Pharmatechnology & Manufacturing Private Limited operates as a manufacturer of pharmaceutical ingredients and formulations. The company was founded in 2007 and is based in Visakhapatnam, India. Eisai Pharmatechnology & Manufacturing Private Limited operates as a subsidiary of Eisai Co. Ltd.

Innova offering quality range of pharmaceutical formulations, drugs, ointments and medicines. Their range is categorized into fluoroquinolone drugs, macrolides drugs, proton pump inhibitor (ppi), cardiovascular drugs, antidiabetic drug, antimalarial drug, nsaid, analgesic & antipyretic drugs, anxiolytic, anticonvulsant & antipsychotic drugs, anticold medicines, anti asthamtic & bronchiodilator drugs, pharmaceutical antimalarial drugs, anesthetic skin ointments and miscellaneous drugs.

The National Institute of Pharmaceutical Education and Research (NIPER) at S.A.S. Nagar (Mohali) created as a centre of excellence in imparting higher education, research and development in pharmaceutical sciences and is the first Institute of its kind in the country.

Marion Biotech strongly believes in an integrated approach to healthcare. It is also engaged in extensive Research & Development of unique Herbal products. At Marion Biotech, we set Stringent Standards of Quality, Safety and Efficacy for all the Products that we manufacture.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’.

Troikaa mainly focuses on Novel Drug Delivery Systems (NDDS). The company firmly believes in providing superior therapeutic benefits by improvising the formulations through Innovative Technologies.
Six patents have been filed in various areas of drug delivery. To handle competition, Troikaa adopted various multifaceted strategies to help stand their ground in the competitive market. Another fact that helps us stand out is their high quality products.

India has, so far, failed to get any assurance from the European Union to reconsider its ban on Indian herbal medicines even though the issue was raised at the EU through the official channel several times.

The ban has come into effect from May 1, 2011, following a new EU regulatory procedure that was approved seven years back.

ABOUT GANPAT UNIVERSITY

PharmaShine - 2011, which is organised by PharmaTutor and OPUBS, met success and called end of the event by announcing Top most articles.

As we announce that Top 3 articles are awarded publication in CYS-International Journal. But we decided that not only three but other also who are near by the winners, will also publish in CYS as merit award after peer review.

About Author: Mr.Mahendra G. Pawar* (B.Pharmacy) Ms.Komal  R. Nikam (B.Pharmacy), Mr.Rakesh D.Amrutkar (M.Pharmacy)

Reference ID: PHARMATUTOR-ART-1059

Abstract
Biotechnologists in recent years have come up with a new concept.This new concept is about edible vaccine. The difference here lies, that crops like “golden rice” provided extra nutrition that naturally didn’t occur in it. But edible vaccines are GM crops that would provide extra added “immunity” from certain diseases.
Edible vaccines are composed of antigenic proteins and do not contain pathogenic genes (because obviously they use attenuated strains). Thus, they have no way of establishing infection and safety is assured.Oral administration is possible , production is highly efficient and can be easily scaled up.For example, hepatitis-B antigen required to vaccinate whole of China annually, could be grown on a 40-acre plot and all babies in the world each year on just 200 acres of land,Cheaper (single dose of hepatitis-B vaccine would cost approximately 23 paise), grown locally using standard methods and do not require immense capital investment of pharmaceutical manufacturing facilities, exhibit good genetic stability. Do not require special storage condition. Since syringes and needles are not used chances of infection are also less. Fear of contamination with animal viruses - like the mad cow disease, which is a threat in vaccines manufactured from cultured mammalian cells - is eliminated, because plant viruses do not infect humans.